Home Newsfeeds Snap Explores Plans to Let Users Showcase NFTs as Filters

Snap Explores Plans to Let Users Showcase NFTs as Filters

-FT https://www.ft.com/content/d6a89a18-4ad4-415a-a810-0ca1668cddc9

byCharles Gross

July 13, 2022

1 minute read

-FT

https://www.ft.com/content/d6a89a18-4ad4-415a-a810-0ca1668cddc9

Canada Approves Novavax’s COVID-19 Vaccine As Booster In Adults

By Vandana Singh

November 18, 1:32 PM

Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older.

NVAX

News

Veradigm Inc. Announces Receipt Of Nasdaq Stay Extension; Pending A Hearing Before The Nasdaq Hearings Panel On November 16, 2023, And The Issuance Of A Final Panel Decision

By Benzinga Newsdesk

October 9, 4:05 PM

Veradigm Inc. (NASDAQ:MDRX) announced today that, on October 6, 2023, it received a notice from Nasdaq indicating that the temporary stay of delisting of the Company's common stock has been extended pending a hearing

MDRX

News

Owlet, Inc. Announces NYSE Acceptance Of Continued Listing Compliance Plan

By Happy Mohamed

July 11, 8:47 AM

Owlet, Inc. (NYSE:OWLT) ("Owlet" or the "Company") today announced that the New York Stock Exchange ("NYSE") has accepted the Company's business plan to regain compliance with

OWLT

News

Blue Water Vaccines To Present At The Universal Influenza Vaccines 2022 Conference In Oxford, United Kingdom On Sept. 5, 2022

By Michael Horton

August 24, 2:02 PM

Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or "the Company") a biopharmaceutical company developing transformational vaccines to address significant global health challenges,

BWV

Snap Explores Plans to Let Users Showcase NFTs as Filters

Related Posts

Canada Approves Novavax’s COVID-19 Vaccine As Booster In Adults

Veradigm Inc. Announces Receipt Of Nasdaq Stay Extension; Pending A Hearing Before The Nasdaq Hearings Panel On November 16, 2023, And The Issuance Of A Final Panel Decision

Owlet, Inc. Announces NYSE Acceptance Of Continued Listing Compliance Plan

Blue Water Vaccines To Present At The Universal Influenza Vaccines 2022 Conference In Oxford, United Kingdom On Sept. 5, 2022